ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer
Peer-Reviewed Publication
Peer-Reviewed Publication
Latest News Releases
Updates every hour. Last Updated: 2-Nov-2026 10:16 ET (2-Nov-2026 15:16 GMT/UTC)
Peer-Reviewed Publication
ESMO 2026: UT MD Anderson highlights innovative approaches to monitor, prevent and treat cancer
Reports and Proceedings
Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases
Reports and Proceedings
Machine learning could help identify people at higher risk of common cancers using routine health data
Reports and Proceedings
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer
Peer-Reviewed Publication
Exploring the potential of immunotherapy in early-stage triple-negative breast cancer
Reports and Proceedings
Personalized cancer vaccine plus immunotherapy reduces melanoma recurrence after surgery
Reports and Proceedings
Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer
Reports and Proceedings
Standard kidney function tests underestimate chronic kidney disease in people with cancer
Reports and Proceedings
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
Peer-Reviewed Publication